DK0804933T4 - Lagerstabile fibrinogenpræparater - Google Patents

Lagerstabile fibrinogenpræparater

Info

Publication number
DK0804933T4
DK0804933T4 DK97106568T DK97106568T DK0804933T4 DK 0804933 T4 DK0804933 T4 DK 0804933T4 DK 97106568 T DK97106568 T DK 97106568T DK 97106568 T DK97106568 T DK 97106568T DK 0804933 T4 DK0804933 T4 DK 0804933T4
Authority
DK
Denmark
Prior art keywords
fbg
acid
lyophilised
vitamin
pyridine
Prior art date
Application number
DK97106568T
Other languages
Danish (da)
English (en)
Other versions
DK0804933T3 (da
Inventor
Thomas Dr Seelich
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7792949&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0804933(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of DK0804933T3 publication Critical patent/DK0804933T3/da
Application granted granted Critical
Publication of DK0804933T4 publication Critical patent/DK0804933T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK97106568T 1996-04-30 1997-04-21 Lagerstabile fibrinogenpræparater DK0804933T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19617369A DE19617369A1 (de) 1996-04-30 1996-04-30 Lagerstabile Fibrinogen-Präparate

Publications (2)

Publication Number Publication Date
DK0804933T3 DK0804933T3 (da) 2004-05-17
DK0804933T4 true DK0804933T4 (da) 2009-06-02

Family

ID=7792949

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97106568T DK0804933T4 (da) 1996-04-30 1997-04-21 Lagerstabile fibrinogenpræparater

Country Status (8)

Country Link
US (1) US5962405A (ja)
EP (1) EP0804933B2 (ja)
JP (1) JP4094701B2 (ja)
AT (1) ATE263586T1 (ja)
CA (1) CA2203961C (ja)
DE (2) DE19617369A1 (ja)
DK (1) DK0804933T4 (ja)
ES (1) ES2218615T5 (ja)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT407117B (de) * 1997-09-19 2000-12-27 Immuno Ag Fibrinschwamm
US7276235B2 (en) 1998-11-18 2007-10-02 Zlb Behring Gmbh Tissue glue with improved antiadhesive properties
ES2258870T3 (es) 1998-11-18 2006-09-01 Zlb Behring Gmbh Preparados proteicos estabilizados para un adhesivo para tejidos.
DE19853033A1 (de) * 1998-11-18 2000-05-25 Centeon Pharma Gmbh Stabilisierte Proteinzubereitung für einen Gewebekleber
JP4771594B2 (ja) * 1999-02-12 2011-09-14 バクスター アクチェンゲゼルシャフト フィブリノーゲンおよびフィブロネクチンをベースとする製剤を生成するための方法ならびにこの方法により入手可能なタンパク質組成物
SI1151007T1 (sl) * 1999-02-12 2006-10-31 Baxter Ag Postopek za pripravo pripravka na osnovi fibrinogena in fibronektina in proteinski sestavki, ki jihlahko dobimo po tem postopku
US7795218B2 (en) 2001-04-12 2010-09-14 Bioaxone Therapeutique Inc. ADP-ribosyl transferase fusion variant proteins
KR20040055782A (ko) * 2001-10-03 2004-06-26 크리스토퍼 제이 울버튼 보관-안정한 인간 피브리노겐 용액
JP2005517638A (ja) * 2001-12-04 2005-06-16 ジェイ．ウールバートン クリストファー 保存安定性のあるフィブリンシーラント
US7622562B2 (en) 2002-06-26 2009-11-24 Zimmer Orthobiologics, Inc. Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
DE10261126A1 (de) * 2002-08-13 2004-03-04 Aventis Behring Gmbh Lagerungsstabile, flüssige Fibrinogen-Formulierung
WO2005058207A1 (en) 2003-12-11 2005-06-30 Isto Technologies, Inc. Particulate cartilage system
US20070014780A1 (en) * 2005-07-13 2007-01-18 Statseal Storage-stable human fibrinogen solutions
CN1911440A (zh) * 2005-08-08 2007-02-14 上海莱士血制品有限公司 一种用于形成纤维蛋白膜的试剂盒及其应用
WO2007025290A2 (en) 2005-08-26 2007-03-01 Isto Technologies, Inc. Implants and methods for repair, replacement and treatment of joint disease
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
WO2008089466A2 (en) * 2007-01-18 2008-07-24 Baxter International Inc. Fibrin gel for controlled release of tgf-beta and uses thereof
US20090012629A1 (en) 2007-04-12 2009-01-08 Isto Technologies, Inc. Compositions and methods for tissue repair
MX2009013970A (es) 2007-06-19 2010-09-10 Baxter Int Gel de fibrina para la liberacion controlada del factor de crecimiento derivado de plaqueta (pdgf) y sus usos.
US20100028311A1 (en) * 2008-07-09 2010-02-04 Baxter International Inc. Using of scaffold comprising fibrin for delivery of stem cells
AR081227A1 (es) 2008-12-11 2012-07-18 Baxter Int Preparaciones basadas en fibrinogenos y polisacaridos sulfatados
CN102781464A (zh) 2010-01-08 2012-11-14 巴克斯特国际公司 用于吸引并保持再生和修复细胞的生物基质
EP2528631B1 (en) * 2010-01-28 2014-08-06 Omrix Biopharmaceuticals Ltd. Method for improved fibrin sealing
ES2951828T3 (es) 2010-09-23 2023-10-25 Leading Biosciences Inc Administración de inhibidores de serina proteasa al estómago
KR101127127B1 (ko) * 2011-10-27 2012-03-21 주식회사 녹십자 고농도 피브리노겐 용액의 제조 방법 및 이를 이용한 피브린 실란트 제품의 제조방법
EP2797681B1 (en) 2011-12-29 2017-02-01 Omrix Biopharmaceuticals Ltd. Method and device for fast dissolution of solid protein composition
ES2645082T3 (es) 2012-03-12 2017-12-04 The Regents Of The University Of California Métodos y composiciones de tratamiento de heridas y reducción del riesgo de hernias incisionales
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
CN110559435B (zh) 2013-09-11 2023-10-20 伊戈尔生物药品股份有限公司 包含离子性液体的液体蛋白质制剂
CA2942358C (en) 2014-03-25 2023-03-28 Leading BioSciences, Inc. Compositions for the treatment of autodigestion
AU2015325055B2 (en) 2014-10-01 2021-02-25 Eagle Biologics, Inc. Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
CN113908282A (zh) 2016-01-11 2022-01-11 恒翼生物医药科技(上海)有限公司 用于治疗和预防粘连及肠梗阻的组合物和方法
IL310285A (en) 2021-08-13 2024-03-01 Biotest Ag Fibrinogen preparations and preparation methods
WO2023129802A1 (en) 2021-12-30 2023-07-06 Baxter International Inc. Fibrinogen and thrombin solutions for a fibrin sealant and fibrin sealant kit

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
AT359652B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
AT371719B (de) * 1980-08-25 1983-07-25 Immuno Ag Verfahren und vorrichtung zur beschleunigung des aufloesens von schwerloeslichen lyophilisierten arzneimitteln
AT369990B (de) * 1981-07-28 1983-02-25 Immuno Ag Verfahren zur herstellung eines gewebeklebstoffes
DE3203775A1 (de) * 1982-02-04 1983-08-11 Behringwerke Ag, 3550 Marburg Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
AT379311B (de) * 1984-03-29 1985-12-27 Immuno Ag Vorrichtung zur applikation eines gewebeklebstoffes
AT397203B (de) * 1988-05-31 1994-02-25 Immuno Ag Gewebeklebstoff
AT396548B (de) * 1990-05-03 1993-10-25 Immuno Ag Biopsieeinrichtung
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
US5290918A (en) † 1993-02-23 1994-03-01 Haemacure Biotech Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation
US5330974A (en) * 1993-03-01 1994-07-19 Fibratek, Inc. Therapeutic fibrinogen compositions

Also Published As

Publication number Publication date
EP0804933B1 (de) 2004-04-07
DK0804933T3 (da) 2004-05-17
ES2218615T3 (es) 2004-11-16
ATE263586T1 (de) 2004-04-15
EP0804933A2 (de) 1997-11-05
JP4094701B2 (ja) 2008-06-04
JPH1036286A (ja) 1998-02-10
US5962405A (en) 1999-10-05
CA2203961C (en) 2008-07-08
EP0804933A3 (de) 2000-03-22
EP0804933B2 (de) 2009-03-11
DE19617369A1 (de) 1997-11-06
DE59711487D1 (de) 2004-05-13
CA2203961A1 (en) 1997-10-30
ES2218615T5 (es) 2009-07-03

Similar Documents

Publication Publication Date Title
DK0804933T4 (da) Lagerstabile fibrinogenpræparater
Elg et al. Effect of activated prothrombin complex concentrate or recombinant factor VIIa on the bleeding time and thrombus formation during anticoagulation with a direct thrombin inhibitor
Gardell et al. Effective thrombolysis without marked plasminemia after bolus intravenous administration of vampire bat salivary plasminogen activator in rabbits.
Stern et al. Endothelium and regulation of coagulation
Fenton et al. Thrombin and antithrombotics
NO885109D0 (no) FremgangsmŸte og middel for Ÿ forhindre blodpropp.
Yao et al. Blockade of platelet membrane glycoprotein Ib receptors delays intracoronary thrombogenesis, enhances thrombolysis, and delays coronary artery reocclusion in dogs.
DK36991D0 (da) Vaevsplasminoaktivator-(t-pa)-variant med zymogene eller fibrinspecifikke eller plasmakoagel-specifikke egenskaber, fremgangsmaade til fremstilling deraf, dna-sekvens, som koder for varianten, replicerbar udtrykkelsesvektor for denne og vaertsceller transformeret med vektoren
ATE321577T1 (de) Stabilisierte proteinzubereitungen für einen gewebekleber
Harrington et al. Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction
ATE53299T1 (de) Blutstillende irrigationsloesung.
Potapov et al. Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device
DK0746334T3 (da) Farmaceutisk præparat indeholdende plasminogenaktivatorer
Lind et al. Oxidative inactivation of plasmin and other serine proteases by copper and ascorbate
John et al. Hirulog: a direct thrombin inhibitor for management of acute coronary syndromes
HU892304D0 (en) Preparation and process for quick desintegration of thrombi
Eisenberg Role of new anticoagulants as adjunctive therapy during thrombolysis
Swedenborg et al. Inactivation of thrombin by the aortic endothelium
DE69001110T2 (de) Thrombolytische zusammensetzung enthaltender gewebetyp, plasminogenaktivatoren oder derivate davon.
Li et al. Antithrombotic and thrombolytic activities of Agkisacutacin, a snake venom proteinase, in experimental models
Violi et al. Effects of ticlopidine on platelet function and blood coagulation
Eisenberg Novel antithrombotic strategies for the treatment of coronary artery thrombosis: a critical appraisal
Fry et al. The nature of synergy between tissue-type and single chain urokinase-type plasminogen activators
Subramaniam et al. Direct thrombin inhibitors
Eikelboom et al. Management of patients with acute coronary syndromes: what is the clinical role of direct thrombin inhibitors?